The Latest Breaking News from Cardinal Health Inc

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

The medical industry has undergone significant expansion in recent times, and is projected to continue growing due to the increasing number of chronic diseases and the swift adoption of technology. Hence, I think fundamentally strong medical stocks McKesson (MCK), Centene (CNC), Cardinal Health (CAH), and Nature’s Sunshine Products (NATR) might…

Recent rhetoric from the Federal Reserve, the collapse of the Silicon Valley Bank, and strong economic data have now resulted in an extremely volatile market backdrop. Against this, adding fundamentally sound stocks Bristol-Myers Squibb (BMY), General Motors (GM), McKesson Corp. (MCK), Cardinal Health (CAH), and American Vanguard (AVD) to your…

Many market analysts predict a recession in 2023 as the Fed continues raising interest rates to control inflation. Amid the uncertainties, retirees looking for steady income generation could consider investing in quality dividend-paying stocks Cardinal Health (CAH) and Sisecam (SIRE) in 2023. Keep reading.

Monthly inflation inched up in January. Moreover, the Fed could be forced to raise the benchmark rate higher than forecasted. Amid this backdrop, it could be wise for investors to buy fundamentally strong stocks Coca-Cola (KO), Bristol-Myers Squibb (BMY), Cardinal Health (CAH), and Bluegreen Vacations Holding (BVH), currently trading under…

The healthcare industry's future looks promising, thanks to the growing medical needs and technological improvements. Also, due to inelastic demand for their products and services, healthcare stocks tend to perform relatively well regardless of the economic situation. Therefore, investors could consider buying fundamentally stable medical stocks Centene (CNC), Cardinal Health…

With the central bank’s progress in controlling inflation, recession risks have subsided. Amid early signs of resilience, the IMF recently upgraded the outlook for the U.S. economy in 2023. Given this backdrop, fundamentally strong stocks Halliburton (HAL), Cardinal Health (CAH), and Jabil (JBL) could be ideal buy-and-hold options for solid…

The medical industry is poised for growth this year, driven by expanding medical needs and increasing federal support. Moreover, the industry is expected to thrive in times of uncertainty due to steady demand. Thus, quality medical stocks McKesson Corp. (MCK) and Cardinal Health (CAH) could be ideal buys this year.…

Despite inflation slowing down, it is still far from the Fed's target. While the pace of rate hikes might slow, the Fed is expected to continue with the increases this year. Therefore, fundamentally sound stocks Sysco (SYY), Cardinal Health (CAH), and Sisecam Resources (SIRE), which pay a steady dividend, might…

The incessant rate hikes have led to significant market volatility and raised recessionary fears. However, with inflation finally cooling and wage growth slowing down, we think fundamentally strong stocks Bristol-Myers Squibb (BMY), Cardinal Health (CAH), and KT Corp (KT), which are rated A (Strong Buy) in our proprietary rating system,…

With the Fed’s continued interest-rate hikes expected to keep markets in perpetual turmoil, it would be opportune to load up on McKesson (MCK). The recession-resistant medical services market leader’s enduring competitive advantages and attractive valuation have also earned it a place in the portfolio of Warren Buffett-led Berkshire Hathaway (BRK).…